Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of ageHirotaka Takasaki, Chizuko Hashimoto, Atsuko Fujita, et al.
Leukemia Research|May 4, 2012
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: serial monitoring after allogeneic stem cell transplantation for acute leukemiaTakuya Miyazaki, Hiroyuki Fujita, Katsumichi Fujimaki, et al.
Leukemia & Lymphoma|November 21, 2008
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemiaHideyuki Koharazawa, Heiwa Kanamori, Rika Sakai, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 12, 2021
Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective StudyHiroyuki Takahashi, Rika Sakai, Takayuki Sakuma, et al.
Leukemia & Lymphoma|September 3, 2011
Pretransplant serum ferritin has a prognostic influence on allogeneic transplant regardless of disease riskTakayoshi Tachibana, Masatsugu Tanaka, Ayumi Numata, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|September 3, 2013
Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphomaNaoto Tomita, Hirotaka Takasaki, Shin Fujisawa, et al.
Cancer Research|November 19, 2013
The transcription factor IRF8 counteracts BCR-ABL to rescue dendritic cell development in chronic myelogenous leukemiaTomoya Watanabe, Chie Hotta, Shin-ichi Koizumi, et al.
International Journal of Clinical Oncology|February 17, 2025
Survey of healthcare professionals' awareness of appearance care for Japanese cancer patients and their institutions' appearance care systems: report from the Japan Society of Clinical OncologyShiho Kuji, Keiko Nozawa, Shoko Toma, et al.
Annals of Hematology|August 1, 2021
Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myelomaTomonori Nakazato, Masao Hagihara, Naohi Sahara, et al.
Leukemia Research|August 10, 2013
Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneReina Watanabe, Naoto Tomita, Kumiko Kishimoto, et al.
Pageof 12